The clinical use of the new antioxidant thiotriazoline in ischemic ophthalmopathies
Mazur, I.A.; Maksimenko, S.F.; Belenichev, I.F.; Taranenko, D.A.; Deriapa, I.V.; Zavgorodniaia, N.G.
Eksperimental'naia i Klinicheskaia Farmakologiia 58(3): 59-62
1995
ISSN/ISBN: 0869-2092 PMID: 7663303 Document Number: 445972
The new antioxidant Thiotriazoline was used in the treatment of patients with retinal vascular occlusive processes. The agent improved retinal metabolism by inhibiting free radical oxidation. Thiotriazoline is superior to alpha-tocopherol acetate in its activity. Unlike the latter, it has no vasodilating effect.
Document emailed within 1 workday
Related Documents
Shiriaeva, L.I.; Dudnikova, L.K.; Vakhrusheva, L.L.; Geĭ, A.K.; Skripkina, V.M. 1987: Use of vitamin e in children with diabetic ophthalmopathies Pediatriia 6: 103Golovanova, E.V.; Kolechkina, I.A. 2012: Experience with thiotriazoline in the treatment of patients with alcoholic liver disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 3: 96-99
Kirpatovskiĭ, V.I.; Nikiforova, N.V.; Kudriavtsev, I.V.; Nadtochiĭ, O.N. 1996: Use of an alpha-tocopherol emulsion for antioxidant protection of ischemic and conserved kidneys Biulleten' Eksperimental'noi Biologii i Meditsiny 121(5): 499-502
Shkliar, A.S. 1980: Effect of the antioxidant, ionol, on blood coagulation in ischemic heart disease Vrachebnoe Delo 9: 52-54
Godin, D.V.; Garnett, M.E. 1989: Altered antioxidant status in the ischemic/reperfused rabbit myocardium: effects of allopurinol Canadian Journal of Cardiology 5(7): 365-371
Kalmykova, V.I.; Nikitina, E.K.; Bezzubov, A.A. 1986: Comparative study of the action of hypolipemic and antioxidant drugs in ischemic heart disease Sovetskaia Meditsina 3: 81-84
Vasil'ev, A.P.; Strel'tsova, N.N.; Gorbunova, T.Iu.; Mal'tseva, I.A.; Zykova, E.L. 2001: Antioxidant and antiarrhythmic activity of carvedilol in patients with ischemic heart disease. Comparison with anaprilin Terapevticheskii Arkhiv 73(10): 65-67
Marubayashi, S.; Dohi, K.; Ochi, K.; Kawasaki, T. 1987: Protective effects of free radical scavenger and antioxidant administration on ischemic liver cell injury Transplantation Proceedings 19(1 Part 2): 1327-1328
Chursina, T.V.; Molchanov, A.V.; Mikhin, V.P. 2007: Lipid peroxidation and antioxidant defense in patients with ischemic heart disease: correction with free-load bicycle exercise Terapevticheskii Arkhiv 79(1): 48-52
Shevchenko, I.A.; Shatilina, L.V.; Borisenko, L.V.; Balliuzek, M.F.; Gurevich, V.S. 1989: Effects of ubinon-9, a synthetic antioxidant, on intensity of lipid peroxidation in blood platelets and plasma of patients with ischemic heart disease Kardiologiia 29(11): 91-95
Markovic, S.; J. Ðordevic; Majkic, N.-Singh; Vasiljevic, Z.; M; Petrovic; Glavinic, L.; S; Letic; Milo, A.ševic 2000: The Importance of Antioxidant Enzyme and Total Antioxidant Status of Patients with Acute Myocardial Infarction on Thrombolytic Therapy Clinical Laboratory 46(9-10): 495-499
Wierzba, T.H. 2005: Unexpected failure of antioxidant clinical trials Kardiologia Polska 63(4 Suppl 2: S472-S482
Błaszczak, R.; Kujawski, K.; Kedziora-Kornatowska, K.; Kornatowski, T.; Kedziora, J.óz.; Szadujkis-Szadurski, L.; Markuszewski, L.; Rysz, J.; Ertel, D.; Olszewski, R. 2005: The total antioxidant capacity and low-molecular antioxidant concentration in plasma of type-2 diabetes patients with different stage of metabolic compensation and concomitant diabetic nephropathy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(103): 29-32
Egorov, E.A.; Shvedova, A.A.; Obraztsova, I.A. 1989: The results of research on the antioxidant emoksipin in clinical eye diseases Vestnik Oftalmologii 105(5): 52-55
Guseva, M.R.; Beslaneeva, M.B. 2010: Clinical rationale for the efficiency of using the domestic antioxidant agent Histochrome Vestnik Oftalmologii 126(3): 37-40
Kniazev, M.D.; Todorov, R.N.; Kirichenko, A.A.; Aslibekian, I.S. 1978: Clinical instrumental and clinical angiographic studies of patients with the anginose forms of ischemic heart disease Vutreshni Bolesti 17(4): 41-47
Dagianti, A.; Fedele, F.; Penco, M.; Agati, L.; Di Renzi, L.; Pastore, L.R.; Sciomer, S.; Iacoboni, C.; Benedetti, G.; Arata, L. 1986: Clinical aspects of the physiopathology of the ischemic event in clinical medicine Cardiologia 31(12): 1157-1165
Namysłowski, G.; Sobczak, A.; Uhma, E. 2003: Activity of the enzymatic antioxidant system depends on the clinical stage of laryngeal cancer Otolaryngologia Polska 57(1): 39-43
Erhola, M.; Nieminen, M.M.; Ojala, A.; Metsä-Ketelä, T.; Kellokumpu-Lehtinen, P.; Alho, H. 1998: Human plasma antioxidant capacity during radiotherapy for lung cancer: a clinical study Journal of Experimental and Clinical Cancer Research: Cr 17(3): 325-330
Aguilera, A.; Bajo, M.A.; del Peso, G.; Diez, J.J.; Codoceo, R.; Rebollo, F.; Mariano, M.; Selgas, R. 2002: True deficiency of antioxidant vitamins e and a in dialysis patients. Relationship with clinical patterns of atherosclerosis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 18: 206-211